AU2001290316A1 - Gata-3 expression inhibitor and method of screening the same - Google Patents

Gata-3 expression inhibitor and method of screening the same

Info

Publication number
AU2001290316A1
AU2001290316A1 AU2001290316A AU9031601A AU2001290316A1 AU 2001290316 A1 AU2001290316 A1 AU 2001290316A1 AU 2001290316 A AU2001290316 A AU 2001290316A AU 9031601 A AU9031601 A AU 9031601A AU 2001290316 A1 AU2001290316 A1 AU 2001290316A1
Authority
AU
Australia
Prior art keywords
gata
screening
same
expression inhibitor
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290316A
Inventor
Shoji Furusako
Yutaka Kato
Takaaki Negishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of AU2001290316A1 publication Critical patent/AU2001290316A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001290316A 2000-10-02 2001-09-28 Gata-3 expression inhibitor and method of screening the same Abandoned AU2001290316A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-302779 2000-10-02
JP2000302779 2000-10-02
PCT/JP2001/008564 WO2002029403A1 (en) 2000-10-02 2001-09-28 Gata-3 expression inhibitor and method of screening the same

Publications (1)

Publication Number Publication Date
AU2001290316A1 true AU2001290316A1 (en) 2002-04-15

Family

ID=18784079

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290316A Abandoned AU2001290316A1 (en) 2000-10-02 2001-09-28 Gata-3 expression inhibitor and method of screening the same

Country Status (2)

Country Link
AU (1) AU2001290316A1 (en)
WO (1) WO2002029403A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050154046A1 (en) * 2004-01-12 2005-07-14 Longgui Wang Methods of treating an inflammatory-related disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5547684A (en) * 1978-09-29 1980-04-04 Takeda Chem Ind Ltd Preparation of antitrichophytosis substance
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders
CN1225682A (en) * 1996-04-23 1999-08-11 哈佛大学校长及研究员协会 Method and compositions for regulating T cell subsets by modulating transcription facter activity

Also Published As

Publication number Publication date
WO2002029403A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU2001245928A1 (en) Electrolyzer and method of using the same
AU2002364528A1 (en) Bio-implant and method of making the same
AU2001252973A1 (en) Biosensor and related method
AU2001268138A1 (en) Method of performing distributed load testing
AU2001288762A1 (en) Detection and characterization of microorganisms
AU2002320456A1 (en) Removable stent and method of using the same
AU2001286254A1 (en) Gasket and method of manufacturing the gasket
AU2001257075A1 (en) Screen and method of making the same
AU2003282558A1 (en) Nanopellets and method of making nanopellets
PL366338A1 (en) Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
AU6774900A (en) Decorative pop-up stickers and method of making the same
AU2001296581A1 (en) Micromachined component and method of manufacture
AU2002230606A1 (en) Glazing unit and method of making the same
AU4256901A (en) Method of screening for inhibitors of osteopontin
AU2001249444A1 (en) Methods and compositions for the simultaneous detection of multiple analytes
AU2002308892A1 (en) Method of evaluating the function of phagocyte and utilization thereof
AU2001272798A1 (en) Method of reformatting web page and method of providing web page using the same
AU2003256647A1 (en) Stencil and method of using the same
AU2001261676A1 (en) Method and reagent for the inhibition of erg
AU2003257118A1 (en) Perforated electret articles and method of making the same
AU2002214189A1 (en) Methods of identifying inhibitory compounds and uses thereof
AU2001280646A1 (en) Display and method of manufacture
AU2001228628A1 (en) Stent-graft assembly and method of making the same
AU2002237253A1 (en) Biosensor and method of producing the same
AU2003276398A1 (en) Shearwall structure and method of making the same